Literature DB >> 7942839

Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.

I M van der Steenstraten1, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer.   

Abstract

Attitudes toward predictive testing programs, in individuals who choose not to undertake the test (i.e., nonparticipants), may be influenced by fears of an unfavorable result. The reasons not to participate in predictive testing programs for Huntington disease (HD) were studied in members of the Dutch Huntington Association who were at 50% risk. They had completed the same baseline psychological questionnaires as had the participants in the Dutch DNA-testing program. The group of 34 nonparticipants was similar to the tested participants in the Dutch predictive testing program, with respect to average age (31.1 years), male:female ratio (1:2), the frequency of a stable relationship (70%), and level of education (67% had high school education or higher). Testing did not seem to be a realistic option for nonparticipants for improving their quality of life. In comparison with participants, nonparticipants had a significantly more pessimistic outlook on themselves and their futures. When asked to consider the possibility of an unfavorable result, nonparticipants expected more difficulties in their families; more problems for their children, their partners, and themselves; a lowered quality of life; and, more often, a depressive reaction. In their opinion, a favorable result would reduce the problems for their children but not for themselves, a result that was found more often in the nonparticipant than in the participant group. Nonparticipants learned about their being at risk for HD during adolescence (mean age 15.6 years), whereas participants did so in adulthood (mean age 22.7 years). The nonparticipants' attitude toward the test might be explained by the influence of HD in the adolescent's separation-individuation process and personality development. This finding could be relevant for future research and for the discussion about testing minors for delayed-onset disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942839      PMCID: PMC1918279     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients.

Authors:  A T Beck; G Brown; R J Berchick; B L Stewart; R A Steer
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

2.  Uptake of presymptomatic predictive testing for Huntington's disease.

Authors:  D Craufurd; A Dodge; L Kerzin-Storrar; R Harris
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

3.  Understanding the decision to take the predictive test for Huntington disease.

Authors:  G J Meissen; C A Mastromauro; D K Kiely; D S McNamara; R H Myers
Journal:  Am J Med Genet       Date:  1991-06-15

4.  Knowledge, attitude, and the decision to be tested for Huntington's disease.

Authors:  K A Quaid; J Brandt; R R Faden; S E Folstein
Journal:  Clin Genet       Date:  1989-12       Impact factor: 4.438

5.  Opinion: predictive testing for Huntington disease in childhood: challenges and implications.

Authors:  M Bloch; M R Hayden
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

6.  Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium.

Authors:  G Evers-Kiebooms; J J Cassiman; H van den Berghe
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

7.  Presymptomatic, prenatal, and exclusion testing for Huntington disease using seven closely linked DNA markers.

Authors:  M I Skraastad; A Verwest; E Bakker; M Vegter-van der Vlis; I van Leeuwen-Cornelisse; R A Roos; P L Pearson; G J van Ommen
Journal:  Am J Med Genet       Date:  1991-05-01

8.  Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.

Authors:  M Bloch; M Fahy; S Fox; M R Hayden
Journal:  Am J Med Genet       Date:  1989-02

9.  Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.

Authors:  J Brandt; K A Quaid; S E Folstein; P Garber; N E Maestri; M H Abbott; P R Slavney; M L Franz; L Kasch; H H Kazazian
Journal:  JAMA       Date:  1989-06-02       Impact factor: 56.272

10.  Intended use of predictive testing by those at risk for Huntington disease.

Authors:  G J Meissen; R L Berchek
Journal:  Am J Med Genet       Date:  1987-02
View more
  32 in total

Review 1.  Psychological impact of genetic testing for Huntington's disease: an update of the literature.

Authors:  B Meiser; S Dunn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

Review 2.  Psychological effect of genetic testing for Huntington's disease: an update of the literature.

Authors:  B Meiser; S Dunn
Journal:  West J Med       Date:  2001-05

Review 3.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

Review 4.  Research issues in genetic testing of adolescents for obesity.

Authors:  Mary E Segal; Pamela Sankar; Danielle R Reed
Journal:  Nutr Rev       Date:  2004-08       Impact factor: 7.110

5.  Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.

Authors:  M Decruyenaere; G Evers-Kiebooms; A Boogaerts; J J Cassiman; T Cloostermans; K Demyttenaere; R Dom; J P Fryns
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

6.  Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease.

Authors:  Yvonne Bombard; JoAnne Palin; Jan M Friedman; Gerry Veenstra; Susan Creighton; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-10       Impact factor: 3.568

7.  (Mis)alignments in counseling for Huntington's Disease predictive testing: clients' responses to reflective frames.

Authors:  Srikant Sarangi; Kristina Bennert; Lucy Howell; Angus Clarke; Peter Harper; Jonathon Gray
Journal:  J Genet Couns       Date:  2005-02       Impact factor: 2.537

8.  Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder.

Authors:  G K Suthers; J Armstrong; J McCormack; D Trott
Journal:  J Med Genet       Date:  2005-12-21       Impact factor: 6.318

9.  The perceived advantages and disadvantages of presymptomatic testing for Machado-Joseph disease: development of a new self-response inventory.

Authors:  Luísa Rolim; José A Zagalo-Cardoso; Constança Paúl; Jorge Sequeiros; Manuela Fleming
Journal:  J Genet Couns       Date:  2006-09-27       Impact factor: 2.537

Review 10.  Why tell asymptomatic children of the risk of an adult-onset disease in the family but not test them for it?

Authors:  P J Malpas
Journal:  J Med Ethics       Date:  2006-11       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.